Literature DB >> 31356113

Lumbar spine radiographs - is it time for widespread adoption of posteroanterior projection?

Christopher Green1, Guru Karnati2, Katharine Thomson3, Ashok Subramanian4.   

Abstract

OBJECTIVE: Phantom studies and a prior patient study have shown up to 53% effective dose reduction when lumbar spine radiographs are acquired posteroanterior (PA) instead of anteroposterior (AP). Since November 2017, Taunton and Somerset NHS Foundation Trust has acquired all standing lumbar spine radiographs PA. The aim of this study was to locally evaluate dose and image quality in both projections and survey current UK practice.
METHODS: 80 outpatients having a standing lumbar spine radiograph (40 AP; 40 PA) had their dose-area product recorded at a constant KV and focus film distance. Effective dose was calculated using PCXMC software. Each blinded radiograph was scored against an optimal reference image using European Guidelines criteria. The data were analyzed using Mann-Whitney U tests and linear regression. Eighty radiologists nationally were sent an anonymous survey to establish their current practice.
RESULTS: A lumbar spine radiograph acquired PA instead of AP reduced effective dose by 41% (p < 0.001) with no difference in image quality (p = 0.9). 21 radiologists completed our survey and only 1 NHS Trust is currently using PA.
CONCLUSION: PA lumbar spine radiography reduces patient radiation exposure with no affect on image quality, acquisition time or cost. The majority of NHS Trusts nationally are still using AP and it is time to standardize to PA. ADVANCES IN KNOWLEDGE: This patient study provides further good evidence of how reduction in exposure to ionizing radiation can be achieved in lumbar spine radiography and more widespread adoption of PA protocol could improve patient safety.

Entities:  

Mesh:

Year:  2019        PMID: 31356113      PMCID: PMC6849682          DOI: 10.1259/bjr.20190386

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  11 in total

Review 1.  Radiation risk from medical imaging.

Authors:  Eugene C Lin
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

2.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

3.  Appendix f: pcxmc--a pc-based monte carlo program for calculating patient doses in medical x-ray examinations.

Authors: 
Journal:  J ICRU       Date:  2005-12

4.  The PA projection of the clavicle: a dose-reducing technique.

Authors:  Mark F Mc Entee; Catherine Kinsella
Journal:  Radiat Prot Dosimetry       Date:  2010-01-09       Impact factor: 0.972

5.  A comparison of radiation dose in examination of the abdomen using different radiological imaging techniques.

Authors:  N W Marshall; K Faulkner; H P Busch; D M Marsh; H Pfenning
Journal:  Br J Radiol       Date:  1994-05       Impact factor: 3.039

6.  Lumbar spine radiology: analysis of the posteroanterior projection.

Authors:  P C Brennan; E Madigan
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

7.  Reducing radiation doses to the breast, thyroid and gonads during diagnostic radiography.

Authors:  G C Weatherburn
Journal:  Radiography       Date:  1983-07

8.  Effective dose reduction in spine radiographic imaging by choosing the less radiation-sensitive side of the body.

Authors:  Avi Ben-Shlomo; Gabriel Bartal; Morris Mosseri; Boaz Avraham; Yosef Leitner; Shay Shabat
Journal:  Spine J       Date:  2015-12-15       Impact factor: 4.166

9.  Effective dose and breast dose reduction in paediatric scoliosis X-ray radiography by an optimal positioning.

Authors:  Avi Ben-Shlomo; Gabriel Bartal; Shay Shabat; Morris Mosseri
Journal:  Radiat Prot Dosimetry       Date:  2013-03-19       Impact factor: 0.972

10.  Comparison of anteroposterior and posteroanterior projection in lumbar spine radiography.

Authors:  Erna Alukic; Damijan Skrk; Nejc Mekis
Journal:  Radiol Oncol       Date:  2018-05-14       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.